Y0001541

Risedronate sodium 2.5-hydrate

European Pharmacopoeia (EP) Reference Standard

• 同義詞: Risedronic acid monosodium salt hemi(pentahydrate)
• 經驗公式（希爾表示法）: C₇H₁₀NNaO₇P₂ · 2.5H₂O
• CAS號碼: 329003-65-8
• 分子量：: 350.13
• MDL號碼: MFCD01706268
• 分類程式碼代碼: 41116107
• NACRES: NA.24

屬性

• 等級: pharmaceutical primary standard
• API 家族: risedronate
• 製造商／商標名: EDQM
• 應用: pharmaceutical (small molecule)
• 格式: neat
• 儲存溫度: 2-8°C
• SMILES 字串: OP(C(P(O)([O-])=O)(O)CC1=CC=CN=C1)(O)=O.[Na+]
• InChI: 1S/2C7H11NO7P2.2Na.5H2O/c2*9-7(16(10,11)12,17(13,14)15)4-6-2-1-3-8-5-6;;;;;;;/h2*1-3,5,9H,4H2,(H2,10,11,12)(H2,13,14,15);;;5*1H2/q;;2*+1;;;;;/p-2
• InChI 密鑰: HYFDYHPNTXOPPO-UHFFFAOYSA-L

描述

一般說明

Risedronate sodium is a member of the pyridinyl class of bisphosphonates. It is mostly used as an antiresorptive agent. It can be used in treating and preventing postmenopausal and glucocorticoid-induced osteoporosis.

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

應用

Risedronate sodium 2.5-hydrate EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

包裝

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

其他說明

Sales restrictions may apply.

安全資訊

• 象形圖: GHS08,GHS07
• 訊號詞: Warning
• 危險聲明: H302,H319,H361,H371
• 防範說明: P201 - P301 + P312 + P330 - P305 + P351 + P338 - P308 + P311
• 危險分類: Acute Tox. 4 Oral - Eye Irrit. 2 - Repr. 2 - STOT SE 2
• 儲存類別代碼: 11 - Combustible Solids
• 水污染物質分類（WGK）: WGK 3
• 閃點（°F）: Not applicable
• 閃點（°C）: Not applicable